Life Science Investing

Oncobiologics Reports First Quarter Fiscal Year 2018 Results

Pharmaceutical Investing

Burcon Announces Completion of Rights Offering

Longevity Investing

MyoKardia Begins Patient Dosing in Phase 1b Clinical Study of MYK-491

Pharmaceutical Investing

Avinger Announces Pricing of $18 Million Underwritten Public Offering

Medical Device Investing

UroGen Pharma Strengthens Management Team with the Appointment of Stephen Mullennix as COO

Pharmaceutical Investing

Agios Reports Fourth Quarter and Full Year 2017 Financial Results

Pharmaceutical Investing

Merus Announces $55.8 Million Private Placement Offering of Common Stock

Genetics Investing

Oncobiologics Receives Positive Nasdaq Listing Determination

Pharmaceutical Investing

Vigil Reports Record Sales Bookings in Third Quarter

Longevity Investing

Tetraphase Announces Top-Line Results from IGNITE3 Phase 3 Clinical Trial of Eravacycline

Pharmaceutical Investing

Invuity Announces Fourth Quarter and Full Year 2017 Financial Results

Medical Device Investing

Latest life science News

More life science News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES